Data as of Jul 31, 2026.

ShareEmbed

BBP holdings: all 67 positions

As of Jul 31, 2026, BBP’s top 10 holdings were 19.6% of the fund, led by Crinetics Pharmaceuticals Inc at 3.34%. It held 67 positions.

Top 10 together
19.6%
Largest position
3.34%
Positions under 1%
2
The answerOne drawing that carries it.
By sector

What BBP holds

More

95% of the weight read, book dated 2026-07-31

The evidenceWhy, in charts and cards.
By country

What BBP holds

More

Share of the fund, positions only, as the fund’s SEC filing states them.

Know what you own

How concentrated the book is

The share of the fund in its largest positions, from the book dated Jul 31, 2026.

Showing Top 10.

Top 10 togetherof 67 positions
19.6%

Most holdings in common with BBP

Open the table

Share of weight both funds hold, from books dated Jul 31, 2026 to Nov 13, 2026.

Largest first

67 of 67 positions

Show all 68 rows
1Crinetics Pharmaceuticals IncCRNX3.34%
2Kiniksa Pharmaceuticals International PLCKNSA1.97%
3Verastem IncVSTM1.95%
4Precigen IncPGEN1.94%
5Omeros CorpOMER1.87%
6Nuvation Bio IncNUVB1.77%
7Regeneron Pharmaceuticals IncREGN1.72%
8Protagonist Therapeutics IncPTGX1.71%
9ACADIA Pharmaceuticals IncACAD1.69%
10Bridgebio Pharma IncBBIO1.65%
11BeOne Medicines LtdONC1.65%
12Xeris Biopharma Holdings IncXERS1.64%
13Halozyme Therapeutics IncHALO1.64%
14Liquidia CorpLQDA1.63%
15Immunocore Holdings PLCIMCR1.61%
16Ironwood Pharmaceuticals IncIRWD1.60%
17Arrowhead Pharmaceuticals IncARWR1.56%
18Roivant Sciences LtdROIV1.55%
19Ligand Pharmaceuticals IncLGND1.55%
20Rhythm Pharmaceuticals IncRYTM1.55%
21Geron CorpGERN1.54%
22Rigel Pharmaceuticals IncRIGL1.54%
23Ascendis Pharma A/SASND1.54%
24Arcutis Biotherapeutics IncARQT1.52%
25Incyte CorpINCY1.52%
26Cytokinetics IncCYTK1.51%
27Moderna IncMRNA1.51%
28Amgen IncAMGN1.49%
29Travere Therapeutics IncTVTX1.48%
30Krystal Biotech IncKRYS1.48%
31Vertex Pharmaceuticals IncVRTX1.48%
32BioMarin Pharmaceutical IncBMRN1.48%
33Zai Lab LtdZLAB1.47%
34Mirum Pharmaceuticals IncMIRM1.47%
35Denali Therapeutics IncDNLI1.46%
36TG Therapeutics IncTGTX1.45%
37Neurocrine Biosciences IncNBIX1.44%
38Syndax Pharmaceuticals IncSNDX1.44%
39Gilead Sciences IncGILD1.43%
40BioCryst Pharmaceuticals IncBCRX1.42%
41ADMA Biologics IncADMA1.42%
42Ultragenyx Pharmaceutical IncRARE1.41%
43Harmony Biosciences Holdings IncHRMY1.41%
44Agios Pharmaceuticals IncAGIO1.40%
45Biogen IncBIIB1.40%
46Theravance Biopharma IncTBPH1.40%
47ImmunityBio IncIBRX1.39%
48Insmed IncINSM1.39%
49BioNTech SEBNTX1.38%
50Exelixis IncEXEL1.38%
51Iovance Biotherapeutics IncIOVA1.37%
52Kura Oncology IncKURA1.37%
53Madrigal Pharmaceuticals IncMDGL1.34%
54Sarepta Therapeutics IncSRPT1.34%
55Crispr Therapeutics AGCRSP1.33%
56Zymeworks IncZYME1.32%
57Tarsus Pharmaceuticals IncTARS1.31%
58United Therapeutics CorpUTHR1.31%
59Aurinia Pharmaceuticals IncAUPH1.29%
60PTC Therapeutics IncPTCT1.25%
61Ardelyx IncARDX1.20%
62Axsome Therapeutics IncAXSM1.18%
63Phathom Pharmaceuticals IncPHAT1.16%
64Novavax IncNVAX1.14%
65Alnylam Pharmaceuticals IncALNY1.00%
66Ionis Pharmaceuticals IncIONS0.97%
67Legend Biotech CorpLEGN0.71%
Cash and other net assets0.20%
More

Source: the fund’s SEC filing (Form N-PORT). Data as of Jul 31, 2026. Updated when the fund files its next report.

About this book

Open the table
FundVirtus Biotech ETF
Positions67
Holdings as of (SEC N-PORT)Jul 31, 2026
SourceForm N-PORT filed with the SEC ↗
Top 10 together19.6%
Cash and other net assets0.20%

What this list is

Cash and other net assets are in their own row and are not a position. A negative weight is a short or an offsetting contract.

Sources

Get an alert

Email me when BBP's holdings change.

Confirm by email. One a day at most, and one click stops it. See Privacy.

Where to next

Copy and cite

Cite this pageCitation, APA and Markdown

ETFIQ, Holdings of BBP, data as of Jul 31, 2026. https://etfiq.com/funds/bbp/holdings/

Open data

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.